Novel in vitro protocol to isolate and expand murine polyclonal Treg cells for efficacy testing in murine models of IBDJOURNAL OF CROHNS & COLITISIF8.72025-01-220PRE
Restoring tumor immunogenicity with dendritic cell reprogrammingSCIENCE IMMUNOLOGYIF16.32023-07-2817OA
Immunogenicity of rat-neu+ mouse mammary tumours determines the T cell-dependent therapeutic efficacy of anti-neu monoclonal antibody treatmentSCIENTIFIC REPORTSIF3.92020-03-035OAAI
CD3-Bispecific Antibody Therapy Turns Solid Tumors into Inflammatory Sites but Does Not Install Protective MemoryMOLECULAR CANCER THERAPEUTICSIF5.52019-02-0474OAAI
High FcγR Expression on Intratumoral Macrophages Enhances Tumor-Targeting Antibody TherapyJOURNAL OF IMMUNOLOGYIF3.42018-12-157OA
FcγR interaction is not required for effective anti-PD-L1 immunotherapy but can add additional benefit depending on the tumor modelINTERNATIONAL JOURNAL OF CANCERIF4.72018-11-1213OAAI
A Restricted Role for FcγR in the Regulation of Adaptive ImmunityJOURNAL OF IMMUNOLOGYIF3.42018-04-1514OAAI
The Adjuvant LT-K63 Can Restore Delayed Maturation of Follicular Dendritic Cells and Poor Persistence of Both Protein- and Polysaccharide-Specific Antibody-Secreting Cells in Neonatal MiceJOURNAL OF IMMUNOLOGYIF3.42012-08-0124OAAI